Johnson & Johnson (JNJ) Tops Q4 EPS by 1c, Beats on Revenue; Reaffirms FY24 Growth Targets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. TSLA

Go back to Johnson & Johnson (JNJ) Tops Q4 EPS by 1c, Beats on Revenue; Reaffirms FY24 Growth Targets

Johnson & Johnson (JNJ) tops revenue estimates, reiterates forecast

January 23, 2024 6:27 AM EST

Johnson & Johnson's (NYSE: JNJ) reported today fourth-quarter results that exceeded analyst expectations.

Adjusted earnings per share (EPS) came in at $2.29, slightly surpassing the average analyst estimate of $2.28. The company also reported sales of $21.40 billion for the quarter, beating the estimated $21.00 billion.

Looking ahead,... More